NSEDisclosure of material issue2 Sept 2026 · 2 Sept 2026, 04:57 pm
Disclosure of material issue
Blue Star Limited · BLUESTARCO
✦ AI SummaryDivestiture
Blue Star Limited has informed about the completion of the sale and transfer of its MedTech business to Cyrix Healthcare Private Limited, effective September 1, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Blue Star Limited has informed regarding Update on completion of sale and transfer of MedTech business of Blue Star Engineering & Electronics Limited, a wholly owned subsidiary of the Company
Attachments (1)
📄pdf
Download →
BLUESTARCO_02092026165704_Stock_Exchange-Update_on_MEdTech_Transfer.pdf
View document text
Blue Star Limited
Band Box House, 4th Floor,
254 D, Dr Annie Besant Road,
Worli, Mumbai 400 030, India.
T : +91 22 6654 4000
E : secretarialdesk@bluestarindia.com
www.bluestarindia.com
September 2, 2026
BSE Limited National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex, Bandra (East),
Mumbai – 400 001 Mumbai – 400 051
BSE Scrip Code: 500067 NSE Symbol: BLUESTARCO
Dear Sir/Madam,
Sub.: Update on completion of sale and transfer of MedTech business of Blue Star
Engineering & Electronics Limited, a wholly owned subsidiary of the
Company
We refer to our letter dated August 14, 2026 (enclosed), wherein we had intimated about
the execution of a Business Transfer Agreement (‘BTA’) by Blue Star Engineering &
Electronics Limited (‘Blue Star E&E’), a wholly owned subsidiary of the Company, with
Cyrix Healthcare Private Limited (‘Cyrix’) for the sale and transfer of Blue Star E&E’s
MedTech business, comprising the business of providing high-end medical diagnostic
equipment and services, as a going concern on a slump sale basis.
In connection therewith, we hereby inform you that Medtech business of Blue Star E&E
has been transferred to Cyrix effective September 1, 2026. The confirmation in this regard
was acknowledged by Cyrix yesterday at 11.30 p.m.
The consideration is payable in tranches, subject to adjustments, if any, in accordance with
the terms of the BTA, with the final tranche payable on March 31, 2027.
This is for your information and record.
The above information is also being placed on the website of the Company at
www.bluestarindia.com
Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road,
Mumbai 400 020, India. T: +91 22 6665 4000
CIN: L 28920MH1949PLC 006870
Blue Star Limited
Band Box House, 4th Floor,
254 D, Dr Annie Besant Road,
Worli, Mumbai 400 030, India.
T : +91 22 6654 4000
E : secretarialdesk@bluestarindia.com
www.bluestarindia.com
Thanking you,
Yours faithfully,
For Blue Star Limited
Rajesh Parte
Company Secretary & Compliance Officer
Membership No.: A10700
Encl: a/a
Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road,
Mumbai 400 020, India. T: +91 22 6665 4000
CIN: L 28920MH1949PLC 006870
Blue Star Limited
Band Box House, 4th Floor,
254 D, Dr Annie Besant Road,
Worli, Mumbai 400 030, India.
T : +91 22 6654 4000
E : secretarialdesk@bluestarindia.com
www.bluestarindia.com
August 14, 2026
BSE Limited National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex, Bandra (East),
Mumbai 400 001 Mumbai 400 051
BSE Scrip Code: 500067 NSE Symbol: BLUESTARCO
Dear Sir/Madam,
Sub.: Intimation under Regulation 30 of Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015
Execution of Business Transfer Agreement by Blue
Star Engineering & Electronics Limited, a wholly owned subsidiary of the
Company.
In compliance with Regulation 30 read with Para A of Part A of Schedule III of the Listing
Regulations, we hereby inform you that the Board of Directors of the Blue Star Engineering
at its
meeting held today i.e. Friday, August 14, 2026, has, inter alia, executed a Business
for the sale and
providing high-
end medical diagnostic equipment and services, as going concern on a slump sale basis,
on such terms and conditions as detailed in the BTA.
The meeting of Blue Star E&E commenced at 6:15 p.m. and concluded at 6:45 p.m.
The details as required under Para A of Part A of Schedule III of the Listing Regulations
and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
The above information is also being placed on the website of the Company at
www.bluestarindia.com
Kindly take the same on record.
Thanking you,
Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road,
Mumbai 400 020, India. T: +91 22 6665 4000
CIN: L 28920MH1949PLC 006870
Blue Star Limited
Band Box House, 4th Floor,
254 D, Dr Annie Besant Road,
Worli, Mumbai 400 030, India.
T : +91 22 6654 4000
E : secretarialdesk@bluestarindia.com
www.bluestarindia.com
Yours faithfully,
For Blue Star Limited
Rajesh Parte
Company Secretary & Compliance Officer
Membership No.: A10700
Encl: a/a
Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road,
Mumbai 400 020, India. T: +91 22 6665 4000
CIN: L 28920MH1949PLC 006870
Blue Star Limited
Band Box House, 4th Floor,
254 D, Dr Annie Besant Road,
Worli, Mumbai 400 030, India.
T : +91 22 6654 4000
E : secretarialdesk@bluestarindia.com
www.bluestarindia.com
ANNEXURE - I
Details as required under the Listing Regulations read with SEBI Master Circular
No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Particulars Description
1. The amount and percentage The MedTech division of Blue Star E&E
of the turnover or revenue or generated a total income of Rs 42.13 crores
income and net worth during the financial year ended March 31, 2026,
contributed by such unit or representing approximately 0.33% of the
division or undertaking or consolidated income from operations
subsidiary or associate for the said year.
company of the listed entity
during the last financial year; As the MedTech division forms an integral part of
the Blue Star E&E
its net worth is not maintained or reported
separately.
As per the audited consolidated financial
statements of the Company for the year ended
March 31, 2026, Blue Star E&E MedTech
division net worth is approximately Rs 7.11 crores
as on March 31, 2026, constituting around 0.21%
2. Date on which the August 14, 2026
agreement for sale has been
entered into;
3. The expected date of Slump Sale of MedTech division of Blue Star E&E
completion of sale/disposal; is proposed to be completed by March 31, 2027,
subject to satisfactory fulfilment of the conditions
precedent, including obtaining all requisite
approvals and completion of such procedures as
may be required, in accordance with the terms of
the BTA.
4. Consideration received from Upto Rs 40,00,00,000 (Rupees Forty Crores), as
such sale/disposal; per the terms of the BTA.
5. brief details of buyers and Cyrix Healthcare Private Limited (Cyrix) is a
whether any of the buyers leading, pan-India Total MedTech Management
belong to the promoter/ Solutions provider with over 22 years of industry
Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road,
Mumbai 400 020, India. T: +91 22 6665 4000
CIN: L 28920MH1949PLC 006870
Blue Star Limited
Band Box House, 4th Floor,
254 D, Dr Annie Besant Road,
Worli, Mumbai 400 030, India.
T : +91 22 6654 4000
E : secretarialdesk@bluestarindia.com
www.bluestarindia.com
promoter group/group experience.
companies. If yes, details
thereof; Cyrix is not a part of the Promoter or Promoter
Group of the Company.
6. whether the transaction This transaction does not fall within the ambit of
would fall within related related party transactions.
party transactions? If yes,
whether the same is done at
7. Whether the sale, lease or Yes, the transaction is outside the scope of the
disposal of the undertaking Scheme of Arrangement.
is outside Scheme of
Arrangement? If yes, details The provisions of Regulation 37A of the SEBI
of the same including Listing Regulations are not applicable to this
compliance with regulation transaction.
37A of Listing Regulations;
Additional disclosure in case of a Slump Sale
8. Name of the entity(is) Please refer to the details specified in point nos.
forming part of the slump (1) and (5) above.
sale, details in brief such as,
size, turnover etc.
9. Whether the transaction This transaction does not fall within the ambit of
would fall within related related party transactions.
party transactions? If yes,
whether the same is done at
10. Area of business of the Seller:
entity(ices); Blue Star Engineering & Electronics Limited (Blue
Star E&E), a wholly-owned subsidiary of Blue Star
Limited, is a leading
[Showing first 8,000 characters — download PDF for full document]